DOV Pharmaceutical, Inc. Report issue

For profit Phase 2 Phase 3
Founded: Hackensack NJ United States (1995)
Status: Acquired by Euthymics BioScience, Inc. (2010) → now Ethismos (2017)

Organization Overview

First Clinical Trial
2004
NCT00295711
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

bicifadine (3 trials)

Drugs in Phase 2 Trials (1)

amitifadine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 3)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Low Back Pain (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 2